Latest News

Heading 1

with a request body that specifies how to map the columns of your import file to the associated CRM properties in HubSpot.... In the request JSON, define the import file details, including mapping the spreadsheet's columns to HubSpot data. Your request JSON should include the following fields:... entry for each column.

Heading 1

with a request body that specifies how to map the columns of your import file to the associated CRM properties in HubSpot.... In the request JSON, define the import file details, including mapping the spreadsheet's columns to HubSpot data. Your request JSON should include the following fields:... entry for each column.

reflecting-on-2024-a-year-of-progress-promise-for-the-pws-community
Reflecting on 2024: A Year of Progress & Promise for the PWS Community
As 2024 draws to a close, we at the Foundation for Prader-Willi Research (FPWR) are reflecting on a year filled with progress, promise, and hope. This year’s achievements wouldn’t have been possible without the incredible dedication of our community—researchers, families,
Questionnaire Measures Hyperphagia in PWS Clinical Trials
Measuring hyperphagia is essential to developing and evaluating treatments for Prader-Willi syndrome (PWS). But because hyperphagia involves complex food-related thoughts and behaviors, researchers need tools specifically designed to capture these experiences. In 2016, Zafgen, Inc. donated its Hyperphagia Questionnaire for
what-you-need-to-know-about-blood-clots-in-pws
Blood Clots in PWS: Risk Factors, Signs & Symptoms
Although rare overall, people with PWS have a higher risk for developing dangerous blood clots than the general population. A blood clot is a mass of blood that has changed from its liquid state into a semi-solid or gel-like form.
2024 FPWR PWS/SYS Research Symposium Retrospective
In September, we were honored to host our annual meeting of researchers, physicians, and pharmaceutical companies interested in Prader-Willi or Schaaf-Yang syndromes. This event is consistently invigorating as the leaders in PWS/SYS research not only share their latest results and
FDA Grants Rare Pediatric Disease Designation to CSTI-500
The FDA has granted Rare Pediatric Disease Designation (RPDD) to ConSynance Therapeutics' new investigational drug, CSTI-500 for the treatment of Prader-Willi Syndrome in children and adolescents. This special status is granted to drugs and biologics intended to treat rare diseases,

Subscribe to hope.

If you're looking for the latest information on Prader-Willi syndrome, you’ve come to the right place. FPWR Updates is your source for up-to-date information.

Heading 1

with a request body that specifies how to map the columns of your import file to the associated CRM properties in HubSpot.... In the request JSON, define the import file details, including mapping the spreadsheet's columns to HubSpot data. Your request JSON should include the following fields:... entry for each column.

Evan and Dr. Fallah